Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb;14(1):16-23.
doi: 10.1049/iet-syb.2018.5069.

Hypoglycaemia-free artificial pancreas project

Affiliations

Hypoglycaemia-free artificial pancreas project

Nicolas Magdelaine et al. IET Syst Biol. 2020 Feb.

Abstract

Driving blood glycaemia from hyperglycaemia to euglycaemia as fast as possible while avoiding hypoglycaemia is a major problem for decades for type-1 diabetes and is solved in this study. A control algorithm is designed that guaranties hypoglycaemia avoidance for the first time both from the theory of positive systems point of view and from the most pragmatic clinical practice. The solution consists of a state feedback control law that computes the required hyperglycaemia correction bolus in real-time to safely steer glycaemia to the target. A rigorous proof is given that shows that the control-law respects the positivity of the control and of the glucose concentration error: as a result, no hypoglycaemic episode occurs. The so-called hypo-free strategy control is tested with all the UVA/Padova T1DM simulator patients (i.e. ten adults, ten adolescents, and ten children) during a fasting-night scenario and in a hybrid closed-loop scenario including three meals. The theoretical results are assessed by the simulations on a large cohort of virtual patients and encourage clinical trials.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Identification from a glycaemic holter of a UVA/Padova virtual patient
Fig. 2
Fig. 2
Ltarget and L^ for θ^2,3=50%θ2,3
Fig. 3
Fig. 3
All adults from UVA/Padova T1DMS, fasting scenario with HFS controller and initial BG at 400 mg/dl
Fig. 4
Fig. 4
CVGA plot in OL for the adolescents of UVA/Padova T1DMS. The diamonds represent the underestimation case and the stars represent the overestimation case
Fig. 5
Fig. 5
CVGA plot with HFS for the adolescents of UVA/Padova T1DMS. The diamonds represent the underestimation case and the stars represent the overestimation case
Fig. 6
Fig. 6
BG and average insulin injection for UVA/Padova T1DMS adolescents, for underestimated bolus injection with HFS controller
Fig. 7
Fig. 7
BG and average insulin injection for UVA/Padova T1DMS adolescents, for overestimated bolus injection with HFS controller

References

    1. Kadish A.H.: ‘Automation control of blood sugar a servomechanism for glucose monitoring and control’, ASAIO J., 1963, 9, (1), pp. 363–367 - PubMed
    1. Trevitt S. Simpson S., and Wood A.: ‘Artificial pancreas device systems for the closed‐loop control of type 1 diabetes: what systems are in development?’, J. Diabetes Sci. Technol., 2016, 10, (3), pp. 714–723 - PMC - PubMed
    1. Medtronic. : ‘The 670 g system ‐ p160017’. Available at https://www.fda.gov/medical‐devices/recently‐approved‐devices/minimed‐67...
    1. Cobelli C. Renard E., and Kovatchev B.: ‘Artificial pancreas: past, present, future’, Diabetes, 2011, 60, (11), pp. 2672–2682 - PMC - PubMed
    1. Gondhalekar R. Dassau E., and Doyle F.J.: ‘Periodic zone‐MPC with asymmetric costs for outpatient‐ready safety of an artificial pancreas to treat type 1 diabetes’, Diabetes, 2011, 60, (11), pp. 2672–2682 - PMC - PubMed

Publication types